Logo image of JVA

COFFEE HOLDING CO INC (JVA) Stock Fundamental Analysis

NASDAQ:JVA - Nasdaq - US1921761052 - Common Stock - Currency: USD

3.28  -0.01 (-0.3%)

Fundamental Rating

5

JVA gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 89 industry peers in the Food Products industry. JVA has an excellent financial health rating, but there are some minor concerns on its profitability. JVA has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year JVA was profitable.
JVA had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: JVA reported negative net income in multiple years.
Of the past 5 years JVA 4 years had a positive operating cash flow.
JVA Yearly Net Income VS EBIT VS OCF VS FCFJVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M

1.2 Ratios

JVA's Return On Assets of 7.77% is fine compared to the rest of the industry. JVA outperforms 78.65% of its industry peers.
With a decent Return On Equity value of 11.05%, JVA is doing good in the industry, outperforming 67.42% of the companies in the same industry.
JVA has a Return On Invested Capital of 9.55%. This is amongst the best in the industry. JVA outperforms 80.90% of its industry peers.
Industry RankSector Rank
ROA 7.77%
ROE 11.05%
ROIC 9.55%
ROA(3y)-1.38%
ROA(5y)-0.28%
ROE(3y)-3.31%
ROE(5y)-1.15%
ROIC(3y)N/A
ROIC(5y)N/A
JVA Yearly ROA, ROE, ROICJVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10

1.3 Margins

JVA has a Profit Margin of 3.76%. This is in the better half of the industry: JVA outperforms 64.04% of its industry peers.
In the last couple of years the Profit Margin of JVA has grown nicely.
Looking at the Operating Margin, with a value of 4.90%, JVA is in line with its industry, outperforming 56.18% of the companies in the same industry.
In the last couple of years the Operating Margin of JVA has grown nicely.
The Gross Margin of JVA (22.77%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of JVA has remained more or less at the same level.
Industry RankSector Rank
OM 4.9%
PM (TTM) 3.76%
GM 22.77%
OM growth 3Y-1.21%
OM growth 5Y42.03%
PM growth 3Y11.54%
PM growth 5YN/A
GM growth 3Y-6.57%
GM growth 5Y-0.2%
JVA Yearly Profit, Operating, Gross MarginsJVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), JVA is creating some value.
JVA has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, JVA has more shares outstanding
There is no outstanding debt for JVA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
JVA Yearly Shares OutstandingJVA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
JVA Yearly Total Debt VS Total AssetsJVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

JVA has an Altman-Z score of 4.53. This indicates that JVA is financially healthy and has little risk of bankruptcy at the moment.
JVA's Altman-Z score of 4.53 is amongst the best of the industry. JVA outperforms 84.27% of its industry peers.
There is no outstanding debt for JVA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 20.07
Altman-Z 4.53
ROIC/WACC1.19
WACC8.02%
JVA Yearly LT Debt VS Equity VS FCFJVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

A Current Ratio of 3.47 indicates that JVA has no problem at all paying its short term obligations.
The Current ratio of JVA (3.47) is better than 87.64% of its industry peers.
JVA has a Quick Ratio of 1.82. This is a normal value and indicates that JVA is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 1.82, JVA belongs to the best of the industry, outperforming 82.02% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.47
Quick Ratio 1.82
JVA Yearly Current Assets VS Current LiabilitesJVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

4

3. Growth

3.1 Past

JVA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 4710.00%, which is quite impressive.
JVA shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 20.87% yearly.
Looking at the last year, JVA shows a quite strong growth in Revenue. The Revenue has grown by 15.77% in the last year.
JVA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.51% yearly.
EPS 1Y (TTM)4710%
EPS 3Y20.87%
EPS 5YN/A
EPS Q2Q%228.46%
Revenue 1Y (TTM)15.77%
Revenue growth 3Y7.13%
Revenue growth 5Y0.51%
Sales Q2Q%9.03%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
JVA Yearly Revenue VS EstimatesJVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
JVA Yearly EPS VS EstimatesJVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 0 0.05 0.1 0.15

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 6.19, the valuation of JVA can be described as very cheap.
JVA's Price/Earnings ratio is rather cheap when compared to the industry. JVA is cheaper than 93.26% of the companies in the same industry.
JVA is valuated cheaply when we compare the Price/Earnings ratio to 28.29, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 6.19
Fwd PE N/A
JVA Price Earnings VS Forward Price EarningsJVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

89.89% of the companies in the same industry are more expensive than JVA, based on the Enterprise Value to EBITDA ratio.
JVA's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 170.88
EV/EBITDA 3.68
JVA Per share dataJVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

The decent profitability rating of JVA may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

JVA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

COFFEE HOLDING CO INC

NASDAQ:JVA (4/21/2025, 4:05:08 PM)

3.28

-0.01 (-0.3%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)03-17 2025-03-17
Earnings (Next)06-16 2025-06-16
Inst Owners16.93%
Inst Owner Change-0.21%
Ins Owners12.74%
Ins Owner Change0%
Market Cap18.73M
Analysts80
Price TargetN/A
Short Float %0.41%
Short Ratio0.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 6.19
Fwd PE N/A
P/S 0.23
P/FCF 170.88
P/OCF 43.11
P/B 0.69
P/tB 0.7
EV/EBITDA 3.68
EPS(TTM)0.53
EY16.16%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.02
FCFY0.59%
OCF(TTM)0.08
OCFY2.32%
SpS14.07
BVpS4.79
TBVpS4.7
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.77%
ROE 11.05%
ROCE 13.21%
ROIC 9.55%
ROICexc 10.37%
ROICexgc 10.55%
OM 4.9%
PM (TTM) 3.76%
GM 22.77%
FCFM 0.14%
ROA(3y)-1.38%
ROA(5y)-0.28%
ROE(3y)-3.31%
ROE(5y)-1.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y6.67%
ROICexcg growth 5Y46.05%
ROICexc growth 3Y10.43%
ROICexc growth 5Y49.92%
OM growth 3Y-1.21%
OM growth 5Y42.03%
PM growth 3Y11.54%
PM growth 5YN/A
GM growth 3Y-6.57%
GM growth 5Y-0.2%
F-Score7
Asset Turnover2.07
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 20.07
Debt/EBITDA 0
Cap/Depr 28.98%
Cap/Sales 0.4%
Interest Coverage 23.41
Cash Conversion 8.59%
Profit Quality 3.63%
Current Ratio 3.47
Quick Ratio 1.82
Altman-Z 4.53
F-Score7
WACC8.02%
ROIC/WACC1.19
Cap/Depr(3y)103.2%
Cap/Depr(5y)119.27%
Cap/Sales(3y)1.09%
Cap/Sales(5y)1.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4710%
EPS 3Y20.87%
EPS 5YN/A
EPS Q2Q%228.46%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)15.77%
Revenue growth 3Y7.13%
Revenue growth 5Y0.51%
Sales Q2Q%9.03%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y4093.4%
EBIT growth 3Y5.83%
EBIT growth 5Y42.75%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y104.17%
FCF growth 3Y16.87%
FCF growth 5YN/A
OCF growth 1Y130.81%
OCF growth 3Y4.86%
OCF growth 5YN/A